Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
2021 · Journal of Hepatology · 286 citations
https://doi.org/10.1016/j.jhep.2021.09.035
F
Fabian Finkelmeier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
228
Papers
5.8K
Citations
35
h-index
68
i10-index
Fabian Finkelmeier is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 35, co-authored 194 publications.
ORCID: 0000-0001-8559-9910Papers by this author
worksA faecal microbiota signature with high specificity for pancreatic cancer
2022 · Gut · 267 citations
https://doi.org/10.1136/gutjnl-2021-324755
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
2023 · Gut · 216 citations
https://doi.org/10.1136/gutjnl-2022-327909
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
2016 · European Journal of Cancer · 200 citations
https://doi.org/10.1016/j.ejca.2016.03.002
Severe 25‐hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study
2014 · Alimentary Pharmacology & Therapeutics · 85 citations
https://doi.org/10.1111/apt.12731
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial–Mesenchymal Transition
2017 · Clinical Cancer Research · 39 citations
https://doi.org/10.1158/1078-0432.ccr-16-1762
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat